Tuesday, april 27 anatomy - Experimental Biology

tuesday
A345 952.6 Toll-like receptor 2 signaling pathway in lung
injury. A. Jezierska, I.A. Kolosova and A.D. Verin. Med. Col.
of Georgia and Bloomberg Sch. of Publ. Hlth., Johns Hopkins
Univ.
A346 952.7 Post-secretory activation of Paneth cell
a-defensins in the cecal and colonic lumen of matrix
metalloproteinase-7-null mice. J.R. Mastroianni, J.K. Costales,
N.H. Salzman and A.J. Ouellette. USC Keck Sch. of Med. and
Med. Col. of Wisconsin.
A347 952.8 Diversity and activation of rhesus Paneth cell
a-defensins. R.A. Llenado, A. Maemoto, M.T. Shanahan and
A.J. Ouellette. Univ. of California, Irvine, Sapporo Higashi
Tokusyukai Hosp., Japan, Univ. of North Carolina at Chapel Hill
and USC Keck Sch. of Med.
A348 952.9 Commensal-epithlial signaling mediated via
formyl peptide receptor. C.C. Wentworth, R. Jones, A. Nusrat
and A. Neish. Emory Univ.
A349 952.10 Escherichia coli K1 induces the upregulation of
CD47 in myeloid dendritic cells. R. Mittal and N.V. Prasadarao.
Childrens Hosp. Los Angeles.
A350 952.11 PKR regulates immunoglobulin class switching
during RSV infection in vivo. S.A. Thakur, Z. Zalinger, T.R.
Johnson, R.A. Corn Minor, B.S. Graham and F. Imani.
NIEHS, NIH, Research Triangle Park and Bethesda and North
Carolina A&T State Univ.
A351 952.12 Bovine pituitary extract interferes with SARS-
CoV replication. T. Jelesijevic, E. Uhl, F. Michel and R.J.
Hogan. Univ. of Georgia Col. of Vet. Med.
953. Role of Extracellular Matrix in
Pathobiology
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 11:30 a m-1:30 p m
A352 953.1 Characterization of chondrocyte differentiation
of ATDC5 cell line induced by ascorbic acid. T.M. Temu, C.
Phornphtkul and P.G. Gruppuso. Warren Alpert Med. Sch.,
Brown Univ.
A353 953.2 Changes in protein profile composition of
coronary luminal membrane induced by ischemia and ischemia/
reperfusion. R. Rubio, B. Arroyo-Flores, A. Barba de la Rosa
and M. Knabb. Autonomous Univ. of SLP and IPICYT, San
Luis Potosi, Mexico and West Chester Univ.
A354 953.3 Effect of trichostatin A on human diabetic
fibroblast migration and matrix metalloproteinase expression.
W.J. Lindblad. Husson Univ. Sch. of Pharm.
A355 953.4 Fibrocytes express several matrix
metalloproteinases: possible role in migration and homing.
C. Garcia de Alba, C. Becerril, S. Reyes, M. Selman and
A. Pardo. Natl. Inst. of Resp. Dis., Mexico City and Natl.
Autonomous Univ. of Mexico.
A356 953.5 Hyaluronan-chondrocyte interactions mediate
cell signaling pathways. N. Luo, C.B. Knudson and W.
Knudson. East Carolina Univ.
A357 953.6 Rac1-mediated H 2
O 2
generation suppresses
MMP-9 expression via ERK. S. Murthy and A.B. Carter. Univ.
of Iowa.
A358 953.7 Characterization of the opioid peptide
dynorphin A as a novel ligand for leukocyte integrin a M
b 2
(Mac-
1). J. Brothwell, N.P. Podolnikova and T.P. Ugarova. Sch. of
Life Sci., Arizona State Univ.
pathology
954. Molecular Pathobiology of Neoplasia
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 11:30 a m-1:30 p m
A359 954.1 Cell phones as a new m-Health opportunity for
mass cervical cancer screening. O. Markovic and N. Markovic.
BioSciCon Inc., Rockville, MD.
A360 954.2 MR angiogenesis imaging with Robo4- versus
alphavbeta3-targeted nanoparticles in the B16/F10 mouse
melanoma model. K. Boles, A. Schmieder, S. Caruthers, G.
Hu, M. Scott, H. Zhang, B. Reynolds, S. Wickline and G.
Lanza. Washington Univ. in St. Louis.
A361 954.3 Molecular histology of tissue using imaging
mass spectrometry and classification analysis. D.S. Cornett,
K. Schwamborn, P. Wild and R.M. Caprioli. Bruker Daltonics,
Billerica, MA,Vanderbilt Univ. and Univ. Hosp. Zurich.
A362 954.4 Modern methods in histo- and cytopathology:
a view from Russia. S.V. Jargin. Peoples’ Friendship Univ. of
Russia.
A363 954.5 An analysis of 1 year versus 3 month alphainterferon
treatment in patients with melanoma stages IIB,
IIC, and IIIA. A. Frankenthaler and M.B. Atkins. Beth Israel
Deaconess Med. Ctr. and Union Col., NY.
A364 954.6 Effect of cancer hereditary susceptibility on the
prognosis of esophageal cancer patients from high esophageal
cancer incidence area in China. X. Li, Z-M. Zhao, Y-Z. Zhang,
F-Y. Zhou, X-H. Hou and H-L. Ji. Xinxiang Med. Univ., First
People’s Hosp. of Zhengzhou, Tumor Hosp. of Anyang, Wuhan
Union Hosp., Tongji Med. Col. of Huazhong Univ. of Sci. and
Technol., People’s Republic of China and Univ. of Texas Hlth.
Sci. Ctr. at Tyler.
A365 954.7 P2 receptors and ATP enhance the migration
of prostate cancer cells. W. Peters, R.A. Sikes, R. Duncan and
C. Maguire. Lincoln Univ. and Univ. of Delaware.
A366 954.8 Lysophosphatidic acid enhances VEGF-C
expression in PC-3 human prostate cancer cells. C-e. Lin, C-H.
Lin, C-L. Chang, Y-L. Huang and H. Lee. Natl. Taiwan Univ.
A367 954.9 Sphingosine 1-phosphate-induced autophagy
is mediated through activating endoplasmic reticulum stress
response in human prostate cancer PC-3 cells. C-J. Shih, Y-L.
Huang, C-L. Chang, W-P. Huang and H. Lee. Natl. Taiwan
Univ.
A368 954.10 The potential of conditionally replicating
adenovirus expressing TIMP2 for ovarian cancer therapy.
S. Yang, J.T. Douglas, R.D. Alvarez, G.P. Siegal and S.
Ponnazhagan. Univ. of Alabama at Birmingham.
A369 954.11 Oligonucleotide-based array CGH analysis of
diffuse large B-cell lymphomas identifies gain of 7q22 as the
most common genomic alteration. E.A. Medina, A.R. Bolla,
R.L. Bandi and R.S. Robetorye. Univ. of Texas Hlth. Sci. Ctr.
at San Antonio.
A370 954.12 Epac1 is upregulated in chronic lymphocytic
leukemic B cells. L. Brown, L. Zhang, T.J. Kipps and P.A.
Insel. UCSD.
A371 954.13 Bowel morphologic evaluation in a model of
experimental intoxication with 1-naphtyl-N-methylcarbamate.
K.P. Cavalcanti, I.A. Souza, R. Castro, N. Teles and A.S.
Cabrita. Fac. of Med., Univ. of Coimbra, Portugal and Univ.
Fed. of Pernambuco, Brazil.
t
u
e
289